Clinical Trials Logo

Clinical Trial Summary

Based on the study about carbon monoxide in human inflammatory and other beneficial physiological function , now we'll be going to research its application in neonates .Phase 1 Study as a foundation for the further test is, the safety and Adverse reaction study of newborn to inhaled CO


Clinical Trial Description

Previous studies have demonstrated that, carbon monoxide has showed the effectiveness such as in inflammation ,apoptosis as well as relaxation of smooth muscle of the body. Now we have a hypothesis to use carbon monoxide in pulmonary hypertension of the newborns, to observe whether it will decrease pulmonary artery hypertension on newborns. Phase 1 study is ,the safety and Adverse reaction study of newborn to inhaled CO , after this,we can master the application of carbon monoxide dose ;


Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Miscellaneous Disorders in the Fetus or Newborn

NCT number NCT01818843
Study type Interventional
Source Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Contact
Status Enrolling by invitation
Phase N/A
Start date April 2012
Completion date December 2013